Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status

BACKGROUND: Expression of the oestrogen receptor (ER) in breast cancer predicts benefit from endocrine therapy. Minimising the frequency of false negative ER status classification is essential to identify all patients with ER positive breast cancers who should be offered endocrine therapies in order...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Li, Qiyuan, Eklund, Aron C., Juul, Nicolai, Haibe-Kains, Benjamin, Workman, Christopher T., Richardson, Andrea L., Szallasi, Zoltan, Swanton, Charles
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995741/
https://ncbi.nlm.nih.gov/pubmed/21152022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0015031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars